Updating the Infection Risk Reduction Hierarchy: Preventing Transition into Injection

Journal of Urban Health

Volumn 81, Issue 1, 2004, Pages 14-19

  Vlahov, David ^a   Fuller, Crystal M ^b   Ompad, Danielle C ^a   Galea, Sandro ^a   Des Jarlais, Don C ^c  

^a NEW YORK ACADEMY OF MEDICINE   (United States)

^b Columbia University ^*  (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Hepatitis C virus; Hierarchy; Human immunodeficiency virus; Infection; Injection drug use; Prevention

Indexed keywords

DISEASE TRANSMISSION; DISINFECTION; HEALTH EDUCATION; HEMATOGENOUS INFECTION; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; INFECTION; INFECTION PREVENTION; INJECTION; INSTRUMENT STERILIZATION; INTRAVENOUS DRUG ABUSE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION;

BLOOD-BORNE PATHOGENS; DISEASE PROGRESSION; HEPACIVIRUS; HEPATITIS C; HUMANS; RISK FACTORS; RISK REDUCTION BEHAVIOR; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 2442602278     PISSN: 10993460     EISSN: None     Source Type: Journal    
DOI: 10.1093/jurban/jth083     Document Type: Review

References (39)

1. US Public Health Service. HIV prevention bulletin: medical advice to persons who inject illicit drugs. May 9, 1997. Available at: http://www.cdc.gov/idu/pubs/hiv_prev.htm. Accessed October 5, 2003.
2. Vlahov D, Munoz A, Anthony JC, Cohn S, Celentano DD, Nelson KE. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am J Epidemiol. 1990;132:847-856.
3. Des Jarlais DC, Friedman SR. HIV infection among intravenous drug users: epidemiology and risk reduction. AIDS. 1987;1:67-76.
4. Mandell W, Vlahov D, Latkin C, Oziemkowska M, Cohn S. Correlates of needle sharing among injection drug users. Am J Public Health. 1994;84:920-923.
5. Johnson J, Williams ML. A preliminary ethnographic decision tree model of injection drug users' (IDUs) needle sharing. Int J Addict. 1993;28:997-1014.
6. Coffin P. Syringe availability as HIV prevention: a review of modalities. J Urban Health. 2000;77:306-330.
7. Des Jarlais DC, Marmor M, Friedmann P, et al. HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health. 2000;90:352-359.
8. Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(suppl 1):S11-S19.
9. van Ameijden EJ, Van den Hoek JA, Mientjes GH, Coutinho RA. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol. 1993;9:255-262.
10. Rezza G, Sagliocca L, Zaccarelli M, Nespoli M, Siconolfi M, Baldassarre C. Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence. Scand J Infect Dis. 1996;28:27-29.
11. van Beek I, Dwyer R, Dore GJ, Luo K, Kaldor JM. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ. 1998;317:433-437.
12. Miller CL, Johnston C, Spittal PM, et al. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology. 2002;36:737-742.
13. Des Jarlais DC, Diaz T, Perlis T, et al. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol. 2003;157:467-471.
14. Layden TJ, Lam NP, Wiley TE. Hepatitis C viral dynamics. Clin Liver Dis. 1999;3:793-810.
15. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health. 1996;86:655-661.
16. Chang CJ, Lin CH, Lee CT, Chang SJ, Ko YC, Liu HW. Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan. Eur J Epidemiol. 1999;15:597-601.
17. Schutz CG, Rapiti E, Vlahov D, Anthony JC. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug Alcohol Depend. 1994;36:129-138.
18. Khoshnood K, Kaplan EH, Heimer R. "Dropouts" or "drop-ins"? Client retention and participation in New Haven's needle exchange program. Public Health Rep. 1995;110:462-466.
19. Thorpe LE, Ouellet LJ, Hershow R, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002;155:645-653.
20. Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health. 2001;91:42-46.
21. Hagan H, Des Jarlais DC. HIV and HCV infection among injecting drug users. Mt Sinai J Med. 2000;67:423-428.
22. Seal KH, Ochoa KC, Hahn JA, Tulsky JP, Edlin BR, Moss AR. Risk of hepatitis B infection among young injection drug users in San Francisco: opportunities for intervention. West J Med. 2000;172:16-20.
23. Thiede H, Romero M, Bordelon K, Hagan H, Murrill CS. Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users. J Urban Health. 2001;78:264-278.
24. Seal KH, Kral AH, Lorvick J, McNees A, Gee L, Edlin BR. A randomized controlled trial of monetary incentives versus outreach to enhance adherence to the hepatitis B vaccine series among injection drug users. Drug Alcohol Depend. 2003;71:127-131.
25. Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health. 2001;91:42-46.
26. Roy E, Haley N, Leclerc P, Cedras L, Blais L, Boivin JF. Drug injection among street youths in Montreal: predictors of initiation. J Urban Health. 2003;80:92-105.
27. Neaigus A, Atillasoy A, Friedman SR, et al. Trends in the non-injected use of heroin and factors associated with the transition to injecting. In: Inciardi J, Harrison LD, eds. Heroin in the Age of Crack Cocaine. Thousand Oaks, CA: Sage; 1998:131-159.
28. Fuller CM, Vlahov D, Ompad DC, Shah N, Arria A, Strathdee SA. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend. 2002;66:189-198.
29. Fuller CM, Vlahov D, Arria AM, Ompad DC, Garfein R, Strathdee SA. Factors associated with adolescent initiation of injection drug use. Public Health Rep. 2001;116(suppl 1):136-145.
30. Substance Abuse Mental Health Services Administration. 2002 National Survey on Drug Use & Health Available at: http://www.samhsa.gov/oas/nhsda.htm#NHSDAinfo. Accessed October 5, 2003.
31. Diaz T, Des Jarlais DC, Vlahov D, et al. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health. 2001;91:23-30.
32. Koblin BA, Factor SH, Wu Y, Vlahov D. Hepatitis C virus infection among noninjecting drug users in New York City. J Med Virol. 2003;70:387-390.
33. Fuller CM, Ompad DC, Galea SG, Wu Y, Koblin B, Vlahov D. Hepatitis C incidence - a comparison between injection and non-injection drug users in New York City. J Urban Health. 2004;81:20-24.
34. Freudenberg N, Silver D, Carmona JM, Kass D, Lancaster B, Speers M. Health promotion in the city: a structured review of the literature on interventions to prevent heart disease, substance abuse, violence and HIV infection in US metropolitan areas, 1980-1995. J Urban Health. 2000;77:443-457.
35. Hamid A, Curtis R, McCoy K, et al. The heroin epidemic in New York City: current status and prognoses. J Psychoactive Drugs. 1997;29:375-391.
36. Caiaffa WT, Vlahov D, Graham NM, et al. Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. Am J Respir Crit Care Med. 1994;150:1493-1498.
37. Casriel C, Rockwell R, Stepherson B. Heroin sniffers: between two worlds. J Psychoactive Drugs. 1988;20:437-440.
38. Casriel C, Des Jarlais DC, Rodriguez R, Friedman SR, Stepherson B, Khuri E. Working with heroin sniffers: clinical issues in preventing drug injection. J Subst. Abuse Treat. 1990;7:1-10.
39. Des Jarlais DC, Casriel C, Friedman SR, Rosenblum A. AIDS and the transition to illicit drug injection: results of a randomized trial prevention program. Br J Addict. 1992;87:493-498.